Adjuvant raloxifene treatment for negative symptoms of schizophrenia

Asian Journal of Psychiatry

Volumn 6, Issue 3, 2013, Pages 254-255

  Dhandapani, Aneelraj ^a   Narayanaswamy, Janardhanan C ^a   Venkatasubramanian, Ganesan ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Estrogen; Negative symptoms; Raloxifene; Schizophrenia

Indexed keywords

CYANOCOBALAMIN; MIRTAZAPINE; RALOXIFENE; RISPERIDONE;

ADJUVANT THERAPY; ADULT; CASE REPORT; CLINICAL GLOBAL IMPRESSION SCALE; CYANOCOBALAMIN DEFICIENCY; DELUSIONAL MISIDENTIFICATION; DEPRESSION; DISEASE DURATION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; LETTER; MARRIED PERSON; NEGATIVE SYNDROME; PARANOID SCHIZOPHRENIA; PERSECUTORY DELUSION; POSITIVE SYNDROME; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; TABLET; VITAMIN SUPPLEMENTATION;

ANTIPSYCHOTIC AGENTS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; RALOXIFENE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 84877149260     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2012.12.014     Document Type: Letter

References (7)

1. Begemann M.J., Dekker C.F., van Lunenburg M., Sommer I.E. Estrogen augmentation in schizophrenia: a quantitative review of current evidence. Schizophrenia Research 2012, 141:179-184.
2. Cyr M., Calon F., Morissette M., Di Paolo T. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. Journal of Psychiatry and Neuroscience 2002, 27(1):12-27.
3. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Progress in Neurobiology 2001, 63(1):29-60.
4. Kulkarni J. Oestrogen-a new treatment approach for schizophrenia?. Medical Journal of Australia 2009, 190(Suppl. 4):S37-S38.
5. Kulkarni J., de Castella A., Fitzgerald P.B., Gurvich C.T., Bailey M., Bartholomeusz C., et al. Estrogen in severe mental illness: a potential new treatment approach. Archives of General Psychiatry 2008, 65(8):955-960.
6. Kulkarni J., Gurvich C., Lee S.J., Gilbert H., Gavrilidis E., de Castella A., et al. Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology 2010, 35(8):1142-1147.
7. Sharma E., Raveendranathan D., Shivakumar V., Jayaram N., Rao N.P., Venkatasubramanian G. Beneficial effects of add-on raloxifene in schizophrenia. Archives of Womens Mental Health 2012, 15:147-148.